D-0725-2022 Class I Terminated
FDA drug recall D-0725-2022 was initiated by Walmart Stores on February 9, 2022 and is designated Class I. Reason for recall: Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an una… The recall status is terminated (terminated December 2, 2022). Affected quantity: unknown.
Recall Details
- Product Type
- Drugs
- Report Date
- March 23, 2022
- Initiation Date
- February 9, 2022
- Termination Date
- December 2, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- unknown
Product Description
Avaphinal Maximum Male Enhancement Sexual Pills, 2000 MG*, packaged in 10 Capsules per carton.
Reason for Recall
Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Distribution Pattern
Nationwide in the USA via www.walmart.com
Code Information
Lot: DK1027, Exp 08/01/2023